Physician profile
Cassandra King
NPI 1831466077
$791.20
in general payments reported to CMS, 2019-2025
11 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $143 · 2023: $96.61 · 2024: $266 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $217.74 | 2023-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.78 | 2024 | Jardiance |
| Cvrx, INC. | $128.19 | 2024-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $78.81 | 2023-2025 | Camzyos |
| Novo Nordisk INC | $53.18 | 2022 | |
| Astellas Pharma US INC | $45.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $41.12 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.44 | 2022-2025 | Lifevest |
| Pfizer INC. | $17.78 | 2025 | |
| Ethicon US, LLC | $17.05 | 2025 | Dermabond Prineo, Surgicel Nu-Knit, Stratafix |
| Boston Scientific Corporation | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.